Lyme disease.
Years before the spirochetal etiology of Lyme disease was determined, the effectiveness of antibiotic treatment for erythema chronicum migrans had been established. Revisions in antibiotic treatment have evolved in concert with a growing understanding of the pathogenesis of Lyme disease. Current treatment recommendations are discussed.
Berger
B W
BW
Department of Dermatology, State University of New York at Stony Brook.
D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use; D015748:Borrelia burgdorferi Group / Q000187:drug effects / Q000302:isolation & purification; D002444:Cefuroxime / Q000031:analogs & derivatives / Q000627:therapeutic use; D002648:Child; D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D015787:Erythema Chronicum Migrans / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D006801:Humans; D008193:Lyme Disease / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D011355:Prodrugs / Q000627:therapeutic use; D017211:Treatment Failure
D000900:Anti-Bacterial Agents; D011355:Prodrugs; D017963:Azithromycin; D002444:Cefuroxime; C040738:cefuroxime axetil